NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-5.22	Insider Own	0.10%	Shs Outstand	61.55M	Perf Week	-28.62%
Market Cap	9.64B	Forward P/E	8.84	EPS next Y	17.89	Insider Trans	-82.38%	Shs Float	58.56M	Perf Month	-40.21%
Income	-272.50M	PEG	-	EPS next Q	-1.49	Inst Own	60.70%	Short Float	10.47%	Perf Quarter	28.05%
Sales	204.80M	P/S	47.07	EPS this Y	44.90%	Inst Trans	21.47%	Short Ratio	1.31	Perf Half Y	50.46%
Book/sh	1.73	P/B	91.39	EPS next Y	413.90%	ROA	-45.90%	Target Price	253.75	Perf Year	1296.64%
Cash/sh	8.27	P/C	19.13	EPS next 5Y	0.00%	ROE	-	52W Range	6.77 - 331.68	Perf YTD	41.78%
Dividend	-	P/FCF	194.77	EPS past 5Y	5.60%	ROI	-	52W High	-48.57%	Beta	1.57
Dividend %	-	Quick Ratio	2.80	Sales past 5Y	-9.50%	Gross Margin	-	52W Low	2419.79%	ATR	28.19
Employees	165	Current Ratio	2.80	Sales Q/Q	6163.40%	Oper. Margin	-	RSI (14)	37.80	Volatility	13.96% 11.09%
Optionable	Yes	Debt/Eq	4.14	EPS Q/Q	-332.20%	Profit Margin	-	Rel Volume	1.23	Prev Close	158.10
Shortable	Yes	LT Debt/Eq	3.62	Earnings	Mar 01 AMC	Payout	-	Avg Volume	4.67M	Price	170.59
Recom	2.00	SMA20	-33.65%	SMA50	-9.24%	SMA200	38.09%	Volume	5,155,447	Change	7.90%

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Mar-29-18

Upgrade

Seaport Global Securities

Neutral → Buy

Mar-05-21 02:13PM	Money worries are holding people back from getting the vaccine Yahoo Finance Video +7.90%
10:01AM	Seniors are rushing to get back on planes: Morning Brief Yahoo Finance Video
09:20AM	Hospitals continue to see chronic staff shortages in sectors treating COVID-19 patients Yahoo Finance Video
06:00AM	Why New COVID Strains May Mean More Revenue for Pfizer and Moderna Motley Fool
06:00AM	This Is the Cheapest Coronavirus Vaccine Stock Right Now Motley Fool
Mar-04-21 02:32PM	Its a split field in Texas over lifted mask mandate: Fort Worth Mayor Yahoo Finance Video -13.89%
02:06PM	Doctor: Texas removing the mask mandate was way too soon and rather foolish Yahoo Finance Video
10:41AM	These 2 Companies May Be the Next to Enter the U.S. Vaccine Market Motley Fool
09:54AM	The U.S. market has potential to be an out-performer once again: strategist Yahoo Finance Video
09:19AM	News From The Vaccine World Benzinga
06:00AM	These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech Motley Fool
Mar-03-21 02:35PM	Senate expected to begin stimulus debate today Yahoo Finance Video -10.86%
02:18PM	Doctor: Health care workers are frustrated and concerned over lifting of virus mandates Yahoo Finance Video
12:37PM	Novavax Partners With Poland's Mabion For COVID-19 Vaccine Production: Bloomberg Benzinga
12:05PM	Novavax Under Pressure As It Guides To Vaccine Data; Is NVAX Stock A Buy? Investor's Business Daily
08:53AM	U.S. Vaccine Shortage Could Soon End With Oversupply Barrons.com
06:15AM	Novavax's COVID Vaccine Trial: Are There Any Yellow Flags So Far? Motley Fool
04:32AM	Shares in Poland's Mabion surge on Novavax vaccine programme deal Reuters
Mar-02-21 01:24PM	Doctor: Even as vaccines progress we cant let our guard down Yahoo Finance Video -14.27%
11:46AM	Coronavirus update: Merck to produce J&J vaccines; CDC launches vaccine finder Yahoo Finance
11:07AM	Why Novavax Stock Is Sinking Today Motley Fool
10:40AM	ROCE Insights For Novavax Benzinga
08:45AM	Haverty Furniture, Noodles & Co, Novavax and Zoom Video highlighted as Zacks Bull and Bear of the Day Zacks
08:43AM	Novavax (NVAX) Loss Widens in Q4, Revenues Top Estimates Zacks
06:01AM	What Really Mattered With Novavax's Q4 Update Motley Fool
05:15AM	Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May Benzinga
Mar-01-21 11:30PM	Novavax CEO Says Its Coronavirus Vaccine Could Win FDA Approval in May Motley Fool
07:17PM	Novavax Hopes to Start Supplying Covid Shots This Spring Barrons.com
06:04PM	Novavax CEO: If FDA waits for US data, 'the lag will be a couple of months' for its vaccine Yahoo Finance
05:48PM	Markets Up Big Monday; Zoom (ZM) Beats, Novavax (NVAX) Misses Q4 Zacks
05:14PM	Novavax CEO on COVID-19 vaccine trial progress Yahoo Finance Video
04:41PM	Market Recap: Monday, March 1 Yahoo Finance Video
04:31PM	UPDATE 3-Novavax COVID-19 shot could be cleared for U.S. use by May -CEO Reuters
04:28PM	Novavax: Q4 Earnings Insights Benzinga
04:20PM	Novavax higher after posting quarterly earnings Yahoo Finance Video
04:20PM	Novavax posts wider quarterly loss, sales jump due to pandemic-related services MarketWatch
04:16PM	Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP Poll Investor's Business Daily
04:06PM	Novavax COVID-19 shot could be cleared for U.S. use by May: CEO Reuters
04:03PM	Novavax COVID-19 shot could be cleared for U.S. use as early as May -CEO Reuters
04:02PM	Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights GlobeNewswire
02:58PM	Genpacts AI platform to process and track 'adverse events' of COVID-19 vaccine Yahoo Finance Video
02:30PM	Novavax, Inc. to Host Earnings Call ACCESSWIRE
01:45PM	Doctor: Do not throw away that chance to get any of the vaccines Yahoo Finance Video
12:33PM	Novavax Loss Widens, Revenue Jumps as COVID Vaccine Effort Progresses TheStreet.com
11:07AM	J&J to roll-out single-shot COVID-19 vaccine this week Yahoo Finance Video
Feb-28-21 07:00PM	Novavax closes in on Covid triumph after 33 years of failure Financial Times
Feb-27-21 09:23AM	15 Fastest Growing Biotech Companies in the US Insider Monkey
Feb-26-21 05:06PM	J&J single-dose COVID-19 vaccine gets green light from FDA Yahoo Finance
03:26PM	Top Small-Cap Stocks for March 2021 Investopedia
01:46PM	Doctor: JNJs single-dose vaccine has the potential to be a game changer Yahoo Finance Video
12:31PM	Endo International plc (ENDP) Q4 2020 Earnings Call Transcript Motley Fool
12:04PM	Vaccine Stocks Drop With J&J Set to Release Third U.S. Shot Bloomberg
08:23AM	Novavax and Takeda Finalize License Agreement for Novavax COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan GlobeNewswire
07:17AM	Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg Benzinga
06:10AM	Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains? Motley Fool
Feb-25-21 02:39PM	Covid-19 has been the perfect storm for adversaries in cybersecurity industry: CrowdStrike Yahoo Finance Video -7.69%
02:13PM	Doctor: New COVID-19 strains come from robust transmission of the virus Yahoo Finance Video
12:40PM	Pfizer Will Test Third Dose of Vaccine to Protect Against Variants Barrons.com
06:08AM	Is Novavax Stock a Buy? Motley Fool
Feb-24-21 04:12PM	Moderna Ships Updated Covid-19 Vaccine to NIH for Testing Barrons.com
01:31PM	Novavax expects U.S. trial data for COVID-19 vaccine at start of April Reuters
08:15AM	Here Are the 2 Most Important Things to Look for in Novavax's Earnings Report Next Week Motley Fool
06:21AM	Takeda Doses First Participant In Novavax COVID-19 Vaccine Study In Japan Benzinga
02:10AM	UPDATE 1-Takeda says first patient given Novavax COVID-19 vaccine in Japan clinical trial Reuters
Feb-23-21 03:54PM	COVID-19 vaccine manufacturing is improving, executives tell Congress Yahoo Finance
02:05PM	Doctor: We could optimistically reach herd immunity by late summer Yahoo Finance Video
10:55AM	Vaccine Makers Promise More Supply as FDA Clears Path for Faster Updates Barrons.com
10:50AM	Lyft partners with CVS to increase accessibility of the COVID-19 vaccine Yahoo Finance Video
08:56AM	J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March MarketWatch
Feb-22-21 05:23PM	Coronavirus update: US surpasses 500K deaths; FDA addresses variants and vaccines Yahoo Finance -11.80%
03:58PM	Why Novavax Stock Sank Today Motley Fool
10:47AM	Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidate MarketWatch
10:05AM	Novavax Takes a Step Toward Approval for Covid-19 Vaccine Barrons.com
08:01AM	Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine Barrons.com
07:47AM	Novavax Achieves Target Enrollment In Pivotal Phase 3 Coronavirus Vaccine Study In US, Mexico Benzinga
07:14AM	UPDATE 2-Novavax completes enrolling 30,000 people in U.S. trial of COVID-19 vaccine Reuters
07:00AM	Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico GlobeNewswire
03:29AM	UPDATE 2-Ukraine expects 15 million Novavax doses starting in July -minister Reuters
Feb-21-21 05:53AM	Novavax Inks Gavi Supply Agreement For 1.1B COVID-19 Vaccine Doses SmarterAnalyst
Feb-20-21 06:45AM	The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains Motley Fool
06:25AM	3 Green Flags for Novavax Investors, and 1 Red Flag Motley Fool
06:08AM	Better Coronavirus Stock: Moderna or Novavax? Motley Fool
Feb-19-21 08:24PM	Why Novavax Stock Popped Today Motley Fool
05:03PM	Novavax Stock at $397 a Share? This Analyst Thinks Its Possible TipRanks
04:22PM	Biden Blames Trump; U.S. Weather Strands Vaccine: Virus Update Bloomberg
12:43PM	Novavax Surges Against On Vaccine Supply Deal; Is NVAX Stock A Buy? Investor's Business Daily
12:14PM	Dow Jones Eyes New High As Caterpillar Rallies; Travel Stocks Break Out Investor's Business Daily
08:14AM	Novavax Unveils Potentially Huge Deal to Supply Vaccines Barrons.com
08:10AM	Novavax On Track To Snap Losing Streak On Massive Vaccine Supply Deal Benzinga
07:25AM	The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga
06:01AM	Forget Ocugen! Here's a COVID Stock That Could Make You Richer Quicker Motley Fool
05:03AM	Novavax Rises on Plan to Supply 1.1 Billion COVID Vaccine Doses to Poor Countries TheStreet.com
Feb-18-21 04:49PM	Novavax Jumps By Double Digits After Inking Massive Covid Supply Deal Investor's Business Daily
04:02PM	Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine GlobeNewswire
12:36PM	Bill Gates says US can avoid a 'fall wave' of COVID-19 Yahoo Finance
11:08AM	Bill Gates: with vaccine acceptance U.S. will be back to normal by fall Yahoo Finance Video
06:30AM	Is Novavax Stock a Good Bet on Coronavirus Vaccines? Motley Fool
Feb-17-21 11:40AM	COVID-19 cases are dropping like a rock: Morning Brief Yahoo Finance Video
06:50AM	2 Top Biotech Stocks to Buy in February Motley Fool
06:46AM	Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT Benzinga

Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase III clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as to allow immunization with much lower doses of antigen. The company is also developing RSV F vaccine for older adults (60 years and older) that is in Phase II clinical trial, as well as for healthy children between six months to five years of age that is in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus that is in Phase I clinical trial; and combination respiratory vaccine to protect against influenza and RSV. Further, the company is developing COVID-19 vaccine for coronavirus that causes pneumonia-like symptoms, which is in preclinical stage. It has a partnership agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Sale	225.48	2,895	652,759	275	Mar 02 05:37 PM
Glenn Gregory M	President, R&D	Feb 18	Sale	269.57	2,434	656,134	2,811	Feb 18 06:59 PM
Glenn Gregory M	President, R&D	Feb 16	Option Exercise	13.16	10,531	138,577	8,523	Feb 18 06:55 PM
Glenn Gregory M	President, R&D	Feb 16	Sale	282.71	5,712	1,614,812	2,811	Feb 18 06:55 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 09	Sale	324.50	194	62,953	287	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Option Exercise	14.73	3,406	50,160	3,309	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Sale	290.46	3,022	877,766	287	Feb 09 07:40 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Option Exercise	18.15	15,022	272,724	15,297	Feb 03 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Sale	241.50	15,022	3,627,789	275	Feb 03 05:37 PM
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,014	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.56	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,262	43,054	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM
EVANS GARY C	Director	Aug 18	Option Exercise	31.02	10,500	325,700	332,479	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Aug 18	Option Exercise	33.56	55,921	1,876,525	57,760	Aug 20 06:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Option Exercise	53.82	46,242	2,488,613	46,517	Aug 20 06:20 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Option Exercise	27.60	8,000	220,800	17,951	Aug 20 06:22 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Option Exercise	50.95	42,788	2,179,986	47,875	Aug 20 06:25 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Sale	148.78	42,788	6,366,182	5,087	Aug 20 06:25 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Sale	146.00	8,000	1,168,000	9,951	Aug 20 06:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Sale	144.33	46,242	6,673,982	275	Aug 20 06:20 PM
Glenn Gregory M	President, R&D	Aug 18	Sale	145.20	55,921	8,119,860	1,839	Aug 20 06:14 PM
EVANS GARY C	Director	Aug 18	Sale	150.44	10,500	1,579,620	321,979	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Jun 18	Option Exercise	42.20	16,749	706,808	18,588	Jun 22 05:29 PM
Glenn Gregory M	President, R&D	Jun 18	Sale	59.53	16,749	997,103	1,839	Jun 22 05:29 PM
YOUNG JAMES F	Director	Jun 03	Buy	48.83	1,500	73,245	1,500	Jun 05 05:04 PM
Herrmann John A III	SVP, General Counsel	May 18	Option Exercise	26.19	12,961	339,448	7,774	May 20 04:35 PM
Herrmann John A III	SVP, General Counsel	May 18	Sale	49.44	12,961	640,792	275	May 20 04:35 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience